MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202611088921 A) filed by Noida Institute Of Engineering & Technology Pharmacy Institute on July 21, 2026, for A Method For Evaluation Of Euphrasia Officinalis Leaf Extract For Anti-Psoriatic And Anti- Arthritic Activity.
Inventors include Dr Avijit Mazumder; Mrs Bhavani Pentela; Mr Aslam Khan; Dr Anjna Rani; Mr Annu Bhati; and Ms Nidhi Sharma.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Disclosed herein is a method (100) for evaluation of euphrasia officinalis leaf extract for anti-psoriatic and anti-arthritic activity, the method (100) comprises procuring fresh leaves of Euphrasia officinalis (102). The method also includes preparing a leaf extract (104). The method also includes performing preliminary phytochemical screening (106). The method also includes conducting an acute oral toxicity test (108). The method also includes administering the extract at selected doses (110). The method also includes evaluating anti-arthritic activity (112). The method also includes evaluating anti-psoriatic activity using a dinitrofluorobenzene-induced psoriasis model (114). The method also includes performing histopathological examination of joint and skin tissues (116). The method also includes analyzing the obtained data (118).
Disclaimer: Curated by HT Syndication.
